Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $83,835 | 35 | 41.5% |
| Consulting Fee | $78,066 | 22 | 38.7% |
| Travel and Lodging | $23,602 | 78 | 11.7% |
| Honoraria | $8,430 | 3 | 4.2% |
| Food and Beverage | $7,869 | 115 | 3.9% |
| Education | $130.01 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $123,023 | 136 | $0 (2024) |
| Sarepta Therapeutics, Inc. | $33,520 | 38 | $0 (2024) |
| PTC Therapeutics, Inc. | $27,791 | 30 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $4,866 | 9 | $0 (2024) |
| Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | $4,530 | 2 | $0 (2023) |
| Genentech USA, Inc. | $3,974 | 4 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $1,480 | 12 | $0 (2023) |
| Genentech, Inc. | $904.96 | 4 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $650.44 | 8 | $0 (2023) |
| Medtronic USA, Inc. | $340.55 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,503 | 18 | CATALYST PHARMACEUTICALS, INC. ($4,866) |
| 2023 | $5,641 | 21 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($2,826) |
| 2022 | $17,758 | 16 | Sarepta Therapeutics, Inc. ($17,510) |
| 2021 | $5,024 | 4 | PTC Therapeutics, Inc. ($5,000) |
| 2020 | $15,354 | 6 | PTC Therapeutics, Inc. ($9,750) |
| 2019 | $8,710 | 12 | PTC Therapeutics, Inc. ($4,409) |
| 2018 | $89,079 | 103 | Biogen, Inc. ($74,265) |
| 2017 | $54,861 | 78 | Biogen, Inc. ($48,606) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ITF Therapeutics LLC | — | Food and Beverage | In-kind items and services | $16.84 | General |
| 10/18/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Honoraria | Cash or cash equivalent | $3,900.00 | General |
| Category: NEUROLOGY | ||||||
| 10/10/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: Neurology | ||||||
| 09/28/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| Category: NEUROLOGY | ||||||
| 09/28/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: NEUROLOGY | ||||||
| 09/28/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $34.19 | General |
| Category: NEUROLOGY | ||||||
| 09/28/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $357.96 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $181.26 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Food and Beverage | Cash or cash equivalent | $124.95 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Travel and Lodging | Cash or cash equivalent | $117.84 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $97.48 | General |
| 08/22/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: Neurology | ||||||
| 03/05/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $130.47 | General |
| 03/05/2024 | Sarepta Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $110.31 | General |
| 03/05/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Neurology | ||||||
| 03/04/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $110.05 | General |
| Category: Neurology | ||||||
| 03/03/2024 | PTC Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $130.30 | General |
| 11/17/2023 | Genentech, Inc. | Evrysdi (Drug) | Travel and Lodging | In-kind items and services | $293.00 | General |
| Category: Neurology | ||||||
| 11/16/2023 | Genentech, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $394.00 | General |
| Category: Neurology | ||||||
| 11/15/2023 | Genentech, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $185.00 | General |
| Category: Neurology | ||||||
| 10/05/2023 | BioMarin Pharmaceutical Inc. | Brineura (Biological) | Food and Beverage | In-kind items and services | $118.64 | General |
| Category: CLN 2 | ||||||
| 09/12/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $40.53 | General |
| 09/11/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $99.07 | General |
| Category: Neurology | ||||||
| 06/14/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Honoraria | Cash or cash equivalent | $2,825.50 | General |
| Category: GENE THERAPY | ||||||
About Dr. Warren Marks, MD
Dr. Warren Marks, MD is a Pediatrics healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285727370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warren Marks, MD has received a total of $201,930 in payments from pharmaceutical and medical device companies, with $5,503 received in 2024. These payments were reported across 258 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($83,835).
Practice Information
- Specialty Pediatrics
- Other Specialties Neurology with Special Qualifications in Child Neurology
- Location Fort Worth, TX
- Active Since 10/02/2006
- Last Updated 02/10/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1285727370
Products in Payments
- SPINRAZA (Biological) $115,502
- EXONDYS 51 (Drug) $11,753
- TECFIDERA (Drug) $5,922
- AGAMREE (Drug) $4,866
- ZOLGENSMA (Biological) $4,530
- Emflaza (Drug) $4,085
- Non-Covered Product (Drug) $3,974
- EMFLAZA (Drug) $1,350
- Evrysdi (Drug) $904.96
- Dysport 300 U-1 (Drug) $303.40
- Dysport (Drug) $239.70
- Brineura (Biological) $188.77
- VNS Therapy (Device) $137.21
- Epidiolex (Drug) $125.79
- ACTIVA (Device) $125.38
- Fintepla (Drug) $125.00
- SYNCHROMED (Device) $111.33
- DYSPORT (Drug) $107.34
- LIORESAL (Device) $103.84
- DISEASE STATE (Drug) $100.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Fort Worth
Anish Ray, Md, MD
Pediatrics — Payments: $159,816
Dr. Shailendra Das, D.o, D.O
Pediatrics — Payments: $22,795
Lane Lanier, Md, MD
Pediatrics — Payments: $10,150
Dolores King, Md, MD
Pediatrics — Payments: $9,293
Dennis Vanloozen, M.d, M.D
Pediatrics — Payments: $4,597
Mrs. Carolyn Lentzsch-Parcells, Md, MD
Pediatrics — Payments: $3,752